Index of reports
> Cases with Mucosal Inflammation (94)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Xeloda (Capecitabine) where reactions include mucosal inflammation. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 94 Next >>
Possible Xeloda side effects in 62 year old female
Reported by a physician from United States on 2012-08-27
Patient: 62 year old female
Reactions: Mucosal Inflammation, Fatigue, Diarrhoea, Mental Status Changes, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Colorectal Cancer Metastatic
Xeloda
Indication: Colorectal Cancer Metastatic
Possible Xeloda side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient:
Reactions: Mucosal Inflammation, Diarrhoea, Palmar-Plantar Erythrodysaesthesia Syndrome
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in 69 year old male
Reported by a physician from Brazil on 2012-08-15
Patient: 69 year old male
Reactions: Mucosal Inflammation
Adverse event resulted in: death
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in female
Reported by a physician from Korea, Republic of on 2012-08-15
Patient: female, weighing 47.9 kg (105.4 pounds)
Reactions: Mucosal Inflammation, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Herceptin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Pertuzumab
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Xeloda
Dosage: date of last dose prior to sae: 28/jun/2012
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-29
Other drugs received by patient: Palonosetron; Chlorpheniramine Maleate; Ircodon; Loperamide; Levofloxacin; Levofloxacin; Potassium Chloride; Spironolactone; Meropenem; Nystatin; Calcium Gluconate; Alginate Sodium; Mannitol; Metoclopramide; Furosemide; Gynobetadine; Meperidine HCL; Chlorhexidine Gluconate; Megestrol Acetate; Fentanyl; Famotidine; Potassium Dihydrogen Phosphate; Ketorolac; Dexamethasone; Pantoprazole; Albuminar-20; Meropenem; Oxytetracycline HCL; Polymyxin B Sulfate; Norepinephrine; Tetracosactrin; Almagate; Calcium Pantothenate / Cyanocobalamin / Nicotinamide / Pyridoxine Hydrochlor; Aprepitant; Aprepitant; Acetaminophen; Povidone Iodine; Pantoprazole; Pantoprazole; Morphine Sulfate; Metronidazole; Levofloxacin; Esomeprazole; Albuminar-20; Albuminar-20; Calcium Citrate with Vitamin D3; Ambroxol; Ondansetron; Dried Ferrous Sulfate; Dexamethasone; Magnesium Sulfate; Morphine Sulfate; Metoclopramide; Ambroxol; Filgrastim; Nicotinamide / Pyridoxine Hydrochloride / Riboflavin / Thiamine Hydrochlorid; Ircodon; Povidone Iodine; Mupirocin; Metronidazole; Levofloxacin; Ondansetron; Combiflex (Unk Ingredients); Metronidazole; Metronidazole; Potassium Chloride; Furosemide; Morphine HCL; Sodium Bicarbonate
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-08-10
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Palmar-Plantar Erythrodysaesthesia Syndrome, Pancytopenia, Febrile Neutropenia, Febrile Infection, Mucosal Inflammation, Agranulocytosis, Diarrhoea, Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Xeloda
Other drugs received by patient: Herceptin; Carboplatin
Possible Xeloda side effects in female
Reported by a physician from France on 2012-08-09
Patient: female
Reactions: Mucosal Inflammation, Death, Nausea, Anaemia, Toxicity To Various Agents, Asthenia, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Avastin
Indication: Colon Cancer
Avastin
Start date: 2010-10-27
End date: 2011-01-27
Xeloda
Indication: Colon Cancer
Start date: 2011-04-15
End date: 2011-08-19
Other drugs received by patient: Leucovorin Calcium; Fluorouracil; Vectibix; Leucovorin Calcium; Fluorouracil; Irinotecan HCL; Oxaliplatin; Oxaliplatin
Possible Xeloda side effects in
Reported by a individual with unspecified qualification from Italy on 2012-08-08
Patient:
Reactions: Stomatitis, Anaemia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Liver Disorder, Mucosal Inflammation, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Indication: Breast Cancer Metastatic
Xeloda
Indication: Breast Cancer Metastatic
Possible Xeloda side effects in female
Reported by a physician from United States on 2012-08-07
Patient: female, weighing 72.9 kg (160.4 pounds)
Reactions: Mucosal Inflammation, Blood Bilirubin Increased, Malaise, Dyspnoea, Dehydration, Palmar-Plantar Erythrodysaesthesia Syndrome, Constipation, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ramucirumab
Indication: Breast Cancer
Start date: 2012-06-15
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-06-15
Other drugs received by patient: Tramadol HCL; Ativan; Compazine; Lisinopril
Possible Xeloda side effects in
Reported by a physician from Spain on 2012-08-07
Patient:
Reactions: Abdominal Pain, Dyspnoea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Mucosal Inflammation, Death, Fatigue, Diarrhoea, Neutropenia, Hypertension, Asthenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Blinded Sorafenib and Blinded Sorafenib
Administration route: Oral
Indication: Breast Cancer
Xeloda
Dosage: drug was used for 14 days every 21 days.
Administration route: Oral
Indication: Breast Cancer
Possible Xeloda side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-08-06
Patient:
Reactions: Vomiting, Anaemia, Pulmonary Embolism, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Peripheral Sensory Neuropathy, Mucosal Inflammation, Diarrhoea, Proteinuria, Neutropenia, Leukopenia
Drug(s) suspected as cause:
Avastin
Dosage: fluorouracil based regimen
Indication: Colorectal Cancer Metastatic
Avastin
Dosage: capecitabine-based regimen
Fluorouracil
Dosage: on day 1
Fluorouracil
Indication: Colorectal Cancer Metastatic
Irinotecan Hydrochloride
Dosage: dose: 150/180 mg/m2 on day 1
Indication: Colorectal Cancer Metastatic
Leucovorin Calcium
Dosage: on day 1
Indication: Colorectal Cancer Metastatic
Oxaliplatin
Dosage: on day 1
Indication: Colorectal Cancer Metastatic
Xeloda
Indication: Colorectal Cancer Metastatic
Possible Xeloda side effects in female
Reported by a physician from Korea, Republic of on 2012-08-01
Patient: female, weighing 47.9 kg (105.4 pounds)
Reactions: Mucosal Inflammation, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Herceptin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Pertuzumab
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Xeloda
Dosage: date of last dose prior to sae: 28/jun/2012
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-29
Possible Xeloda side effects in female
Reported by a physician from Korea, Republic of on 2012-07-31
Patient: female, weighing 47.9 kg (105.4 pounds)
Reactions: Mucosal Inflammation, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Herceptin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Pertuzumab
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Xeloda
Dosage: date of last dose prior to sae: 28/jun/2012
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-29
Possible Xeloda side effects in 80 year old female
Reported by a physician from Lebanon on 2012-07-26
Patient: 80 year old female
Reactions: Skin Exfoliation, Pancytopenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Mucosal Inflammation, Diarrhoea, Skin Discolouration, Neutropenia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in female
Reported by a physician from United States on 2012-07-25
Patient: female
Reactions: Pruritus, Stomatitis, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Ulcer, Mucosal Inflammation, Neuropathy Peripheral, Hyperaesthesia, Diarrhoea, Skin Ulcer, Rash Erythematous, Hypophagia, Tenderness, Blister
Drug(s) suspected as cause:
Xeloda
Other drugs received by patient: Atenolol; Venlafaxine HCL; Aredia; Acetaminophen / Hydrocodone Bitartrate; Gargle Solution (Chamomile / Dexpanthenol / Myrrh / Oleum Menthae Piperitae /; Protonix; Prochlorperazine Maleate; Vicodin; Claritin; Extra Strength Tylenol; Iron Sulphate
Possible Xeloda side effects in 60 year old female
Reported by a physician from Germany on 2012-07-25
Patient: 60 year old female
Reactions: Mucosal Inflammation, Renal Failure, Dehydration, Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Indication: Breast Cancer
Start date: 2012-01-01
Xeloda
Indication: Breast Cancer
Start date: 2012-01-01
Other drugs received by patient: Metformin Hydrochloride
Possible Xeloda side effects in female
Reported by a physician from United States on 2012-07-23
Patient: female, weighing 72.9 kg (160.4 pounds)
Reactions: Blood Bilirubin Increased, Mucosal Inflammation, Dyspnoea, Malaise, Dehydration, Palmar-Plantar Erythrodysaesthesia Syndrome, Constipation, Ascites
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ramucirumab
Indication: Breast Cancer
Start date: 2012-06-15
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-06-15
Other drugs received by patient: Compazine; Tramadol Hydrochloride; Lisinopril; Ativan
Possible Xeloda side effects in female
Reported by a physician from United States on 2012-07-23
Patient: female
Reactions: Mucosal Inflammation, Oral Mucosal Blistering, Pneumonia, Diarrhoea
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-07-19
Patient: female
Reactions: Weight Decreased, Pulmonary Embolism, Pyrexia, Hyperhidrosis, Cardiac Disorder, Intestinal Perforation, Dyspepsia, Proteinuria, Epistaxis, Gingival Bleeding, Anaemia, Cardiomyopathy, Neutropenia, Hypersensitivity, Bone Pain, Pain, Chills, Skin Reaction, Abdominal Pain Upper, Polyneuropathy, Myalgia, Fatigue, Oedema, Dizziness, Myocardial Infarction, Nail Toxicity, Thrombocytopenia, Decreased Appetite, Vomiting, Dyspnoea, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Cerebrovascular Accident, Dysgeusia, Mucosal Inflammation, Anxiety, Diarrhoea, Impaired Healing, Arthralgia, Hypertension, Asthenia, Leukopenia
Drug(s) suspected as cause:
Avastin
Indication: Breast Cancer
Herceptin
Indication: Breast Cancer
Xeloda
Indication: Breast Cancer
Possible Xeloda side effects in female
Reported by a physician from Korea, Democratic People's Republic of on 2012-07-16
Patient: female, weighing 47.9 kg (105.4 pounds)
Reactions: Mucosal Inflammation, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Herceptin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Pertuzumab
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Xeloda
Dosage: date of last dose prior to sae: 28/jun/2012
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-29
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-07-16
Patient: female, weighing 66.0 kg (145.2 pounds)
Reactions: Mucosal Inflammation, Fatigue, General Physical Health Deterioration, Haematotoxicity
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: last dose prior to sae on 18 nov 2010. on day 1
Indication: Breast Cancer
Vinorelbine Tartrate
Dosage: on day 1+8. last dose prior to sae on 18 november 2010.
Indication: Breast Cancer
Xeloda
Dosage: dose: 1000 mg/m2. on day 1-14. last dose prior to sae on 02 dec 2010.
Administration route: Oral
Indication: Breast Cancer
Possible Xeloda side effects in female
Reported by a physician from United States on 2012-07-12
Patient: female, weighing 69.9 kg (153.8 pounds)
Reactions: Weight Decreased, Stomatitis, Anaemia, Pancytopenia, Blood Count Abnormal, Death, Mucosal Inflammation, Dehydration, Diabetes Mellitus Inadequate Control, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Xeloda
Other drugs received by patient: Aranesp
Possible Xeloda side effects in 58 year old female
Reported by a physician from United States on 2012-07-11
Patient: 58 year old female, weighing 89.0 kg (195.8 pounds)
Reactions: Mucosal Inflammation, Stomatitis, Diarrhoea, Erythema, Photodermatosis
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Start date: 2012-04-13
Xeloda
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2012-03-22
End date: 2012-04-02
Other drugs received by patient: Acetaminophen / Hydrocodone Bitartrate; Loperamide
Possible Xeloda side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-11
Patient: female
Reactions: Oral Mucosal Blistering, Mucosal Inflammation, Pneumonia, Diarrhoea
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-07-11
Patient: female, weighing 65.0 kg (143.0 pounds)
Reactions: Mucosal Inflammation, Vomiting, Nausea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Possible Xeloda side effects in female
Reported by a physician from Germany on 2012-07-03
Patient: female, weighing 80.0 kg (176.0 pounds)
Reactions: Mucosal Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Paclitaxel
Dosage: date of last dose prior to sae: 20/jun/2012
Indication: Breast Cancer
Start date: 2012-05-16
Xeloda
Dosage: date of last dose prior to sae: 26/jun/2012
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-05-16
Other drugs received by patient: Bisoprolol Plus; Levothyroxine Sodium
Possible Xeloda side effects in female
Reported by a physician from South Africa on 2012-06-27
Patient: female, weighing 77.0 kg (169.4 pounds)
Reactions: Cheilitis, Mucosal Inflammation, LIP Swelling, Gastrointestinal Inflammation, LIP Infection, LIP Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Xeloda
Other drugs received by patient: Valproate Sodium; Zoledronic Acid; Glucophage; Concor
Possible Xeloda side effects in
Reported by a individual with unspecified qualification from Germany on 2012-06-25
Patient:
Reactions: Blood Bilirubin Increased, Proctitis, White Blood Cell Count Decreased, Abdominal Pain, Vomiting, Nausea, Radiation Skin Injury, Palmar-Plantar Erythrodysaesthesia Syndrome, Mucosal Inflammation, Diarrhoea
Drug(s) suspected as cause:
Xeloda
Dosage: two cycles
Administration route: Oral
Indication: Rectal Cancer
Xeloda
Administration route: Oral
Possible Xeloda side effects in 59 year old female
Reported by a physician from France on 2012-06-22
Patient: 59 year old female, weighing 50.0 kg (110.0 pounds)
Reactions: Proctocolitis, Gastrointestinal Inflammation, Pancytopenia, Cholestasis, Haematotoxicity, Hypokalaemia, Mucosal Inflammation, Overdose, Diarrhoea, Alopecia, Hypomagnesaemia, Hypocalcaemia, Pancreatitis, Mucous Membrane Disorder
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Xeloda
Other drugs received by patient: Crestor; Progesterone
Possible Xeloda side effects in female
Reported by a individual with unspecified qualification from France on 2012-06-20
Patient: female, weighing 66.0 kg (145.2 pounds)
Reactions: Abdominal Pain, Myalgia, Mucosal Inflammation, Stomatitis, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Vinflunine
Dosage: cycle 1: 475 mg
Indication: Breast Cancer Metastatic
Start date: 2011-03-23
End date: 2011-03-23
Xeloda
Dosage: cycle 1: 2800 mg
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-03-23
End date: 2011-03-25
Other drugs received by patient: Furosemide; Lexomil; Metformin HCL; Atenolol; Lescol; Hyzaar; Diosmine
Possible Xeloda side effects in 70 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-12
Patient: 70 year old female
Reactions: Breast Lump Removal, Oral Surgery, Localised Infection, Swelling Face, Buccal Mucosal Roughening, Metastases To Liver, Mucosal Inflammation, Osteonecrosis of JAW, Neoplasm Malignant, JAW Disorder, Bone Disorder, Lymphadenectomy, Metastases To Bone, Infection
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Product Used FOR Unknown Indication
Epirubicin Hydrochloride
Indication: Product Used FOR Unknown Indication
Fluorouracil
Indication: Product Used FOR Unknown Indication
Gemcitabine
Indication: Product Used FOR Unknown Indication
Methotrexate
Indication: Product Used FOR Unknown Indication
Pamidronate Disodium
Dosage: drug name reported as pamidronate disodium for injection
Indication: Product Used FOR Unknown Indication
Taxotere
Indication: Product Used FOR Unknown Indication
Xeloda
Indication: Product Used FOR Unknown Indication
Page 1 Next >>
|